Cargando…
An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022
INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired particip...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560374/ https://www.ncbi.nlm.nih.gov/pubmed/37814648 http://dx.doi.org/10.46234/ccdcw2023.161 |
_version_ | 1785117719954194432 |
---|---|
author | Wang, Wenrong Peng, Fangda Ding, Chunguang Li, Tao Wang, Huanqiang |
author_facet | Wang, Wenrong Peng, Fangda Ding, Chunguang Li, Tao Wang, Huanqiang |
author_sort | Wang, Wenrong |
collection | PubMed |
description | INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired participants, which included patients with pneumoconiosis and dust-exposed workers. We employed ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology in targeted lipidomics to investigate serum target phospholipids. Initially, a pilot study was conducted with a selection of 24 pneumoconiosis patients and 24 dust-exposed workers, using both univariate and multivariate statistical analyses to preliminarily identify significant differences in phospholipids. Subsequent to this, the remaining subjects were engaged in a validation study, wherein receiver operating characteristic (ROC) analysis was performed to further substantiate the screening potency of potential lipid biomarkers for pneumoconiosis. RESULTS: The pilot study revealed significantly reduced serum levels of 16∶0 lysophosphatidylcholines (Lyso PC), 18∶0–18∶1 phosphatidylglycerol (PG), 18∶0–18∶1 phosphatidylethanolamine (PE), 18∶0 PE, and 18∶1 lysophosphatidylethanolamine(Lyso PE) in the case group in comparison to the control group. Additionally, 18∶0 PE, 18∶0–18∶1 PE, and 18∶1 Lyso PE emerged as significant phospholipids with superior diagnostic values [area under the curve (AUC)>0.7]. A diagnostic model was established, built on 16∶0 PC and 18∶0 PE (AUC>0.8). In the ROC analyses of validation studies, the 18∶0–18∶1 PE and this diagnostic model demonstrated excellent screening efficiency (AUC>0.7). DISCUSSION: A significant divergence in phospholipid metabolism has been observed between pneumoconiosis patients and dust-exposed workers. The 18∶0–18∶1 PE present in serum could potentially function as a lipid biomarker for pneumoconiosis. Additionally, diagnostic models were developed relying on 16∶0 PC and 18∶0 PE, proving to have superior screening efficiency. |
format | Online Article Text |
id | pubmed-10560374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-105603742023-10-09 An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 Wang, Wenrong Peng, Fangda Ding, Chunguang Li, Tao Wang, Huanqiang China CDC Wkly Methods and Applications INTRODUCTION: Pneumoconiosis emerges as the most critical and prevalent occupational disease in China at present, according to research. Studies indicate that pneumoconiosis may indeed impact the body’s phospholipid metabolism. METHODS: In this study, serum samples were taken from 46 paired participants, which included patients with pneumoconiosis and dust-exposed workers. We employed ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology in targeted lipidomics to investigate serum target phospholipids. Initially, a pilot study was conducted with a selection of 24 pneumoconiosis patients and 24 dust-exposed workers, using both univariate and multivariate statistical analyses to preliminarily identify significant differences in phospholipids. Subsequent to this, the remaining subjects were engaged in a validation study, wherein receiver operating characteristic (ROC) analysis was performed to further substantiate the screening potency of potential lipid biomarkers for pneumoconiosis. RESULTS: The pilot study revealed significantly reduced serum levels of 16∶0 lysophosphatidylcholines (Lyso PC), 18∶0–18∶1 phosphatidylglycerol (PG), 18∶0–18∶1 phosphatidylethanolamine (PE), 18∶0 PE, and 18∶1 lysophosphatidylethanolamine(Lyso PE) in the case group in comparison to the control group. Additionally, 18∶0 PE, 18∶0–18∶1 PE, and 18∶1 Lyso PE emerged as significant phospholipids with superior diagnostic values [area under the curve (AUC)>0.7]. A diagnostic model was established, built on 16∶0 PC and 18∶0 PE (AUC>0.8). In the ROC analyses of validation studies, the 18∶0–18∶1 PE and this diagnostic model demonstrated excellent screening efficiency (AUC>0.7). DISCUSSION: A significant divergence in phospholipid metabolism has been observed between pneumoconiosis patients and dust-exposed workers. The 18∶0–18∶1 PE present in serum could potentially function as a lipid biomarker for pneumoconiosis. Additionally, diagnostic models were developed relying on 16∶0 PC and 18∶0 PE, proving to have superior screening efficiency. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023-09-22 /pmc/articles/PMC10560374/ /pubmed/37814648 http://dx.doi.org/10.46234/ccdcw2023.161 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Methods and Applications Wang, Wenrong Peng, Fangda Ding, Chunguang Li, Tao Wang, Huanqiang An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title | An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title_full | An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title_fullStr | An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title_full_unstemmed | An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title_short | An Analysis of Targeted Serum Lipidomics in Patients with Pneumoconiosis — China, 2022 |
title_sort | analysis of targeted serum lipidomics in patients with pneumoconiosis — china, 2022 |
topic | Methods and Applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560374/ https://www.ncbi.nlm.nih.gov/pubmed/37814648 http://dx.doi.org/10.46234/ccdcw2023.161 |
work_keys_str_mv | AT wangwenrong ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT pengfangda ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT dingchunguang ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT litao ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT wanghuanqiang ananalysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT wangwenrong analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT pengfangda analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT dingchunguang analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT litao analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 AT wanghuanqiang analysisoftargetedserumlipidomicsinpatientswithpneumoconiosischina2022 |